Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Paslakis

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Fortschritte Der Neurologie-Psychiatrie|December 1, 2010
[The role of the glutamatergic system in pathophysiology and pharmacotherapy for depression: preclinical and clinical data]G Paslakis, P Gass, M Deuschle
Medical Hypotheses|May 26, 2012
Intranasal insulin-like growth factor I (IGF-I) as a plausible future treatment of depressionG Paslakis, W F Blum, M Deuschle
Der Nervenarzt|January 26, 2011
[Epigenetic mechanisms in major depression]G Paslakis, S Bleich, H Frieling, et al.
Fortschritte Der Neurologie-Psychiatrie|July 19, 2013
[Adult attention deficit/hyperactivity disorder, associated symptoms and comorbid psychiatric disorders: diagnosis and pharmacological treatment]G Paslakis, M Schredl, B Alm, et al.
Pharmacopsychiatry|December 17, 2011
The differential effect of risperidone and olanzapine on insulin sensitivity after 3 weeks of treatment: a HOMA pilot studyG Paslakis, M Deuschle, J Thome, et al.
Der Nervenarzt|January 29, 2010
[Methylphenidate. Therapy option for adults with ADHD and comorbid substance use disorder?]G Paslakis, F Kiefer, A Diehl, et al.
Pharmacopsychiatry|March 20, 2012
Insulin secretion and sensitivity after single-dose amisulpride, olanzapine or placebo in young male subjects: double blind, cross-over glucose clamp studyD Kopf, M Gilles, G Paslakis, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Fortschritte Der Neurologie-Psychiatrie|December 1, 2010
[The role of the glutamatergic system in pathophysiology and pharmacotherapy for depression: preclinical and clinical data]G Paslakis, P Gass, M Deuschle
Medical Hypotheses|May 26, 2012
Intranasal insulin-like growth factor I (IGF-I) as a plausible future treatment of depressionG Paslakis, W F Blum, M Deuschle
Der Nervenarzt|January 26, 2011
[Epigenetic mechanisms in major depression]G Paslakis, S Bleich, H Frieling, et al.
Fortschritte Der Neurologie-Psychiatrie|July 19, 2013
[Adult attention deficit/hyperactivity disorder, associated symptoms and comorbid psychiatric disorders: diagnosis and pharmacological treatment]G Paslakis, M Schredl, B Alm, et al.
Pharmacopsychiatry|December 17, 2011
The differential effect of risperidone and olanzapine on insulin sensitivity after 3 weeks of treatment: a HOMA pilot studyG Paslakis, M Deuschle, J Thome, et al.
Der Nervenarzt|January 29, 2010
[Methylphenidate. Therapy option for adults with ADHD and comorbid substance use disorder?]G Paslakis, F Kiefer, A Diehl, et al.
Pharmacopsychiatry|March 20, 2012
Insulin secretion and sensitivity after single-dose amisulpride, olanzapine or placebo in young male subjects: double blind, cross-over glucose clamp studyD Kopf, M Gilles, G Paslakis, et al.
Pageof 1